Inventory of medical and social care of children with cerebral palsy in Brittany: Preliminary results  by Sacaze, E. et al.
e abilit
T
d
o
T
t
r
a
D
h
t
o
T
o
R
[
h
A
[
d
C
P
i
A
a
S
b
∗
K
O
i
a
i
M
m
a
R
a
m
s
D
a
a
F
B
p
a
G
c
2
d
C
P
c
c
F
a
M
b
c
K
O
d
M
c
t
s
e
t
a
R
c
R
t
a
t
a
a
d
a
D
i
i
t
p
C
a
w
F
G
2
F
P
d
C
I
c
E
∗
T
w
M
p
a
w
d
C
R
c
a
m
I
o
n
o
I
(
(
1
5
f196 Abstracts / Annals of Physical and Reh
he scapula was of PCH was more internally rotated (10◦, P < 0.05) at rest and
uring most movements. Posterior tilt of the scapula was limited at the end
f abduction, flexion and during the movement of hand-to head (8◦, P = 0.09).
here were few significant differences in scapular lateral rotation. Meanwhile,
he glenohumeral joint showed compensation as excessive amplitude of external
otation in abduction (10◦, P = 0.02) and larger range of motion in flexion and
bduction.
iscussion.– These original data encourage exploration of thoraco-scapulo-
umeral motion in child. The scapulothoracic joint seems more limited than
he glenohumeral joint. They are probably correlated with the overall function
f the upper and encouraged to monitor the future of these children’s shoulder.
he pathophysiology of these changes remains unknown: postural abnormalities
r secondary bone deformities?
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bjective.– Few studies have considered pain prevention during botulinum toxin
njections. There is no consensus on the premedication to use. We wish to list the
nalgesic procedures used for children undergoing botulinum toxin injections
n France.
aterial and method.– We carried out a national phone survey, during two
onth, among 64 medical doctors. Questions dealt with indications for general
naesthetic, pain prevention, procedure assessment, and satisfaction.
esults.– The equimolar mix of oxygen and N2O is often used; analgesic or
nxiolytic premedication is used by some. Non-pharmacological pain manage-
ent therapies were widely used, but the way of using them varied. Some pain
cale were used for pain evaluation.
iscussion.– Despite miscellaneous pain prevention protocols, 64% of people
sked were satisfied, less than 20% of session are difficult for 91% of people
sked.
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ambart G. Evaluation of analgesic protocol with nitrous oxide and EMLA
ream during botulinum toxin injections in children. Ann Readapt Med Phys
007 Jun;50(5):275–9.
oi:10.1016/j.rehab.2011.07.437
O29-004–EN
reliminary study on the interest of applying anesthetic
ream before intramuscular botulinum toxin injections in
hildren and adolescents with cerebral palsy
. Metté a, B. Parratte b, S. Burlot c
Rééducation, centre hospitalier de Mayotte, BP 04, 97600 Mamoudzou,
ayotte
CHU de Besanc¸on, Besanc¸on, France
Hôpital d’Enfants, Saint-Denis, France
eywords: Pain; Cerebral palsy; Botulinum toxin
D
G
dation Medicine 54S (2011) e185–e204
bjective.– To study the interest in using an anesthetic cream to prevent pain
uring botulinum toxin injections in children and adolescents with cerebral palsy.
ethod.– Pain was evaluated in two populations of children and adolescents with
erebral palsy during botulinum toxin injections. Anesthetic cream was applied
o one group at least one hour before the injections at predetermined injection
ites. The other group received their injection without anesthetic cream. Pain was
valuated by an EVA score or on a CHEOPS scale according to the capacity of
he patient. Reaction to the gestures was evaluated by the practitioner as “strong,
verage, weak, nil”.
esults.– Eighty-six cerebral palsy patients between 2 and 20 years old parti-
ipated in the study. The clinical forms were variable (GMFCS classification).
eactivity was evaluated for all patients. Forty-six of them were able to evaluate
heir pain with an EVA score. For the other 40 patients, pain was evaluated on
CHEOPS scale. Forty-seven were given the anesthetic cream and 39 received
heir injection without cream. The 2 populations were homogeneous concerning
verage age and clinical form of the cerebral palsy. The reactivity of the patients
nd the average of the evaluations of pain during injection were not significantly
ifferent for the 2 groups. Analyses according to age, the number of muscles
nd limbs concerned added nothing in favor of the anesthetic cream.
iscussion.– Other factors like the different waiting time before injection
nfluenced the patient’s anxiety. In these groups, the results do not indicate an
nterest in using anesthetic cream to decrease perceived pain during botulinum
oxin injections for children and adolescents with cerebral palsy. The number of
atients in this study was insufficient to be statistically significant.
onclusion.– This work does not provide any evidence favoring application of
nesthetic cream before injecting botulinum toxin in children and adolescents
ith cerebral palsy to decrease the inflicted pain.
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he aim of this study was to evaluate the medical and social care of children
ith cerebral palsy (CP) in Brittany.
aterial and methods.– A questionnaire was constructed to identify social care,
laces of rehabilitation and education, medication, devices, frequency of medical
nd paramedical care. The questionnaires were distributed to parents of children
ith CP via a network of Brittany’s professionals involved in the care of chil-
ren with CP during 1 year. Stratified results by age and Gross Motor Function
lassification Classification System (GMFCS) were performed.
esults.– Ninety-two out of 450 questionnaires distributed were analyzed. The
hildren were 41.4% of type I, 18.5% II, 14.1 III, IV 13% and 13% V and had
mean age of 8.2 years (2–16 years). Children GMFCS I and II were mostly
ainstreamed children while III and IV were either mainstreamed or were in a
EM. Fifty percent of parents of children with GMFCS V did not work while 20%
f parents of children with GMFCS I worked. Sixty-three percent of children did
ot take medication. The first class represented was the antiepileptic drugs (16%
f children). Children receiving botulinum toxin injections were mainly classes
II and IV. The types of doctors the most represented were the general practitioner
70 to 100% of children in classes according to GMFCS) and the physiatrists
75% to 100%). Paramedics the most involved were physical therapists (95 to
00%), occupational therapists (30 to 75%) and psychomotor therapist (19 to
0%). 86.8% of parents believed that the care answered to the problems that
aced them.
iscussion.– One of the difficulties of the study was to obtain the care of children
MFCS IV and V of a greater age.
oi:10.1016/j.rehab.2011.07.439
